ELECTROLYTE SOLUTIONS AND IN VITRO USE THEREOF

Abstract: Processes and compositions for in vitro use in tissue culture media (preferred), perfusion media, and incubation media. Thus, balanced salt solutions are provided wherein the milliequivalent ratio of sodium cations to chloride anions is normalized and wherein optionally at least one near-equilibrium couple is incorporated (bicarbonate<->/carbon dioxide, L-lactate<->/pyruvate<->, and d-betahydroxybutyrate<->/acetoacetate<->). Regulation of intracellular and extracellular pH, and normalization of intracellular redox state and phosphorylation state is achievable.

Description: ELECTROLYTE SOLUTIONS AND IN VITRO USE THEREOF DESCRIPTION This invention lies in the field of in vitro techniques and compositions for replenishing fluid electrolytes and nutrients while regulating metabolic processes in living animal cells. State of the Art The vital functions of highly developed organisms are closely dependent on the internal aqueous medium and on the maintenance in it of extreme constancy of chemical and physical properties. Typically in vitro fluids of this type are aqueous electrolyte solutions which are used to contact living cells in, for examples, 1) incubation of tissue slices, minces or homogenates, 2) perfusion of isolated organs as kidney's, liver, muscles, or heart, 3) incubations of isolated cell suspensions such as isolated adipocytes, hepatocytes, blood cells, myocytes etc., and 4) most p-articularl , electrolytes or "balanced salt mixtures" in which media cells in culture are grown after the optional addition thereto of a host of various nutrients, such as vitamins, sugars, amino acids, hormones, and the like. As will be shown all of other famous solutions, e.g. , Hank's (Proc Soc Exp Biol Med 7].: 196,1949) , Delbecco's (J Ex£ Med 9_9: 167-182,1954) , Earle's (J Nat'l Cane Inst 4: 165-212,1943) , etc., used in the tissue culture art are very simple variations of only 2 basic solutions - usually Krebs-Henseleit (Krebs HA, Henseleit KA. Hoppe-Seyler' s %_ Physiol Chem 210: 33-66, 1932) with variations for the excessive Ca 2+ used by Krebs, and Krebs-Ringer-Phosphate (Krebs HA. Hoppe-Seyler' s Z_ Physiol Chem 217: 193, 1933) , where for convenience of the experimenter buffereing of the pH is achieved with excessive Pi (inorganic phosphate) rather than with HC0 3 " /C0 2 . -\ ~ ~\t~ ' .~~ . _ In this disclosure we propose the first major basic advance in these solutions for the in vitro art since Kreb's attempted to correct the abnormal Na:Cl ratio present in all such solutions in 1950 (Krebs HA. Biochem Biophys Acta 4: 249-269, 1950). It has long been recognized that all animal intracellular and extracellular body fluids contain inorganic electrolytes , and that these electrolytes are involved in, and profoundly influence, various life processes. Attempts to make artificial electrolyte fluids which may bathe tissues or be administered to the human blood stream have been known since about 1880, and, although modern analytical tools and procedures have clarified compositional details of blood electrolytes, the use of various aqueous electrolyte solutions for in vitro purposes in tissue culture, organ perfusion and related fields has long been extant. Those inorganic electrolytes characteristically found in normal human blood serum at respective concen- tration levels above about 1 millimolar per liter of concentration are shown below in Table I. Also, for comparative purposes, in Table I are shown some repre¬ sentative compositions of various aqueous electrolyte solutions that have been previously prepared and used for in vitro purposes. In general, the philosophy behind the formulation of aqueous electrolyte solutions for in vitro use has been that such should mimic or closely resemble the chemical composition of electrolytes in blood, (plasma) extracellular fluids and intracellular fluids. An electrolyte is a substance (usually a salt, acid or base) which in solution dissociates wholly or partly into electrically charged particles known as ions (the term is also sometimes used in the art to denote the solution itself, which has a higher electrical conductivity than the pure solvent, e.g. water). The positively charged ions are termed cations while the negatively >a ; . * \ ~- : charged ions are termed anions. Strong and weak electrolytes are recognized. The dissociation of electrolytes is very markedly dependent on concentration; it increases with increasing dilution of the solution. The ions can be regarded as molecules in electrolyte solutions. Because of dissociation considerations, the term "sigma" or the greek letter for sigma (" ") is sometimes employed herein as a prefix to designate the total presence of a specified material, such as an electrolyte, whether or not all of the material is in an ionic form complexed with a heavy metal, or regardless of charge on the material in a given solution. A pair of brackets [ ] indicates the free concentration of the substance indicated as opposed to that bound to tissue components, such as proteins. - ■?*. _ _ r~. —. -, _—_* • < * ;yr' «_ t!_ *r -l-~- 5 * - ■ ' - A *- Table I. Prior Art Simulated Plasaa Electrolyte Solutions for Contacting Living Cells in Vitro. (1) (2) (3 ) (4) (S) (6) (7 ) Units oπul Noraal Noraal Ringer's Kaau an Lactated Lactated Acetated Plasaa Saline Saline Injection Ringer's Ringer's Ringer's Ringer's aoles ftE.J. H. 0.9* aCl 0.95* NaCl U.S. U.K. U.S. (Hartunn) 263, 1285 U U..SS.. U U..KK.. 1 Canada L fluid 1970 Na 136 - US 154 162.5 147 156.4 130 129.8 130 K 3.5 - 5.0 4 5.4 4 5.4 4 Ca 2.1 - 2.6 2.5 1.15 1.5 0.9 1.5 free [Ca2+] [ 1.06 ] *- Mg 0.75 - 1.25 1.0 free Mg2+. I 0.53 3 " I -£q Cations 142.7-153.2 154 162.5 156 164.1 137 139 137 M l 100 - 106 154 162.5 156 161.7. 109 Ul.B 109 IC03 26 - 28 2.4 I Pi 1 - 1.45 _ ! ,l SO4 0.32 - 0.94 L - lactate 0.6 - 1.8 2B(d, l) 27.2(d, l) pyruvate Lact/pyr D-fl-OHbutyrate acetoacetatc i-HB/ acac acetate 28 Other I _£q anions 128.7-139.4 154 1 16622..55 1 15566 1 16644..1 137 139 137 Na/Cl 1.28 - 1.45 1.00 1 1..0000 0 0..9944 0 0..9977 1.23 1.16 1.19 Glucose 19 - 5.6 ] oorr ootthheerrss Cfl2 0.99 - 1.39 ≠- 7.35 - 7.45 '5.5-6.5 ε5.5-£.5 S5.5-6.5 «7.0 ϊ D . 285. - 295 308 325 309 324 272.5 276 272.5 i -1 l 'physiological uline" in the U.S. is a 0.9* or 154 aM. (Bilaan AG, βoodaan LS, Bilaan A. The Pharaacoloqical Basis of Theraputics (1980) pp 848-884, McMillan, London. 2) "Physiological Saline* in the ULK. is 0.95* NaCl. (Die* K. ed. Docuiwenta Beiov (1962) pp 333-334, Geigy, Manchester. 3) All -Ringer's solutions" are derived froa Ringer S. Physiol 4, 29, I 222, 1893 and 7, 291, 1886. This coββercial U.S. ( version is froa Facts and Coaparisons. Oct 981, p.50, Lippincott, St. Louis. 4) Froa Best and Taylor, Physioloqical Basis g: Medical Practice.6th edition, Baltiaore, 1950. 5) Froa Facts and Coaparisons p.50, Oct '81, I ppincott, St Louis. "- 6) Hartaam AF. J Aa Med Assoc 103: 1349-1354, 1934. 7) Fox CL rt al. I f__ Med Assoc 148: 825-833, 1952. Table I (Cont'd) Prior Art Siaulated Plasaa Electrolyte Solutions for Contacting Living Cells in Vitro. (B) (9) (10) (11) (12) (13) (14 ) Units Noraal Locke's Tyrode's Krebs Krebs Krebs Krebs Krebs Plasaa HHeennsseelleeii tt RRiinnggeeir Serua laproved Iaproved ■aoles N.E.J.M. Phosphate Substitute Ringer II Ringer HI 2B3, 1285 Ca 2+ free Low HCO3- L fluid 1970 LON Pi Na 136 - 145 157.57 150.1 143 150.76 140.31 147.41 140.66 K 15 - 5.0 3.57 5.9 5.9 5.92 5.92 5.92 5.92 ) Ca 2.1 - 2.6 2.16 1.6 2.5 2.54 2.54 2.54 free ICa2+] t 1.06 ] Q Kg 0.75 - 1.25 0.45 1.2 l.lβ 1.16 l.lβ 1.16 U C. free Mg2+] t 0.53 ] ' • . £q Cations 142.7-153.2 165.46 160.5 156.3 164. 12 153.7 155.69 154.22 f.'J Cl 100 - 106 163.92 147.46 127.6 131.51 104.62 10106 122.36 NCO3 26 - 28 3.57 11.9 25 24.9 3.56 3.56 I Pi 1 - 1.45 1.22 l. lβ 17.38 . lβ 15.03 149 S0A 0.32 - 0.94 1.18 l. lβ l. lβ l. lβ 1.16 L - lactate 0.6 - 1.6 pyruvate 4.92 4.92 4.92 Lact/pyr D-0-OHbutyrate acetoacetate l-HB/ acac acetate Other fw-arate " 5.39 5.39 5.39 llutaaate " 4.92 4.92 4.92 £q anions 126.7-139.4 167.49 161.6 157.3 163.97 152.49 156.64 155.17 Na/Cl 1.26 - 1.45 0.96 1.02 1.12 1.15 1.34 1.43 1.15 Slucose 19 - 5.6 5.6-13.9 5.6 11.5 11.5 11.5 rl or others i. -4 C0 2 0.99 - 1.39 1.24 1.24 - • i PH 7.35-7.45 7.1 7.4 7.4 7.4 57.6 17.6 l ib-m 285 - 295 336 318. β 308 311.7 309.6 304.1 307.8 π Use: HI (6) Locke FS. Zbl Physiol S 66, 1694; H, 670, 1900; 490, 1901. (9) Tyrode KJ. Arch int Phamacodvn 20, 205, 1910. (10) Krebs HA, Henseleit KA. _______ -Seyle's 1 Physiol Cheti 210.33-66, 1932. (11 ) Kr«bs HA. Hoppe-Seyle's Z Physiol Chea 217. 193, 1933. (12 ) - 14) Krebs HA. Biochea Biophys Acta __ 249-269, 1950. Table II. "Prior Art Perfusion Fluids" (15) (16 ) (17) (IB) (19) (20) Units Noraal Krebs Schiaassek Krebs Hepatocyte Bahlaan Fulgraff Plasaa Liver Per- Liver Kidney Incubat ion Kidney Kidney ■rales N.E.J.M. fusion aith Perfusion Perfusion Perfusion Perfusion 283, 1285 Bovine serua L fluid 1970 Albuain and Red Cells Na 136 - 145153 151.54 146 153 147 143 K 15 - 5.0 5.9 5.9 5.9 5.9 4.9 4.74 2.1 -2.6 2.5 l.β 2.5 2.5 2.56 1.25 free _Ca2*l I 1.06 _ .J g 0.75 - I.£5 1.2 0.49 1.2 1.2 1.2 0.59 free Wg2*J t 0.531 €q Cations ; 142.7-153.2 166.3 162.02 161.3 166.3 159.4 151.15 l 100 - 106 127.6 147.46 127.8 . 127.6 127 11104 HCO3 26 - 28 25 11.9 25 25 24.5 25 I Pi 1 - 1.45 l. lβ 1.22 1.16 l. lβ 1.18 l. lβ so* 0.32-0.94 l. lβ - 1.2 1.2 l. lβ l. lβ L - lactate 0.6 - l. β (10 Na-1 Lac) 1.33 5 Na 1-Lac 9.09 2.75(d, l ) 15(?d, l) pyruvate 0.09 0.91 0.25 0.25 Lact/pyr 14.8 10 10 7 or 14 D-fl-OHbutyrate acetoacetate acetate 5.0 Other D-Eq anions 126.7-139.4167.0 162.61 162.3 167.0 1S9.1 151.31 Na/Cl 1.26-1.451.12 1.03 1.16 1.20 1.20 1.26 (1.20) βlucose 19-5.6 5.45 6.2 - or others 6.7 urea 6.7 urea σ * C02 0.99-1.391.25 1.24 1.24 1.24 1.24 1.24 -.' • ) ≠- 7.35-7.457.4 7.1 7.4 7.4 7.4 7.4 ) 'i laOsa 265 - 295326 321 316 328 327 107.9 Albuain (fl«) 15-S 19 2.5 5 2.5 5.5 0.05 • Artificial perfusion fluid generally add 1.5 to 8 g* albuain, dialyzed against a aediua listed in Table I; that is Krebs-Henseleit (10), Krebs-Ringer Phosphate (11), Tyrode's (9), Locke's (β), or Krebs-Henseleit with a lowered Ca 2+ ' to the 1 ■_. range, particularly in heart perfusion. They aay or aay not contain red cells. Krebs-Henseleit is known to contain about twice the aβount of ionized Ca 2+ as serua. n *- 15) Heas R, Ross B0, Berry m, Krebs 1. Biochea J 101, 2*4, 1966; Krebs Henseleit (10) with 19 g. x>vine albuain. 16) Schaassek H. Biochea ι 336, 460, 163. Essgptially Tyrode's (9) with added lactate and pyruvate. ^ 17) Nishiitsutsuji-ϋMO Ji , Ross BD, sbs HA. Biochea J 103, 652-662, 1967; Krebs-Henseleit (10) wi JI 5g< albuairς dry. 18) Crow KE, Cornell NU, Jeech RL. Bi hea I ______ 29-36^ 1976, Krebs-Henseleit (10) with 2.5 gX dialysed albuain plus 1-lactate plus pyruvate. 19) Bahlaan J. et al. (b j Physio) 212.771967; Krtbs Henseleit (10) aith lactate and pyruvate and 5.5 g≠ bovine albuain. 20) Fulgraff ct al. fech int Pharaacodvn 172.49, 1972; Krebs-Henseleit (10) with 1/2 Mg and Ca plus lactate and pyruvate, plus 5 aM acetate, plus 0.05 gf albuain plus 2 g* heaocel. Table III 'Balanced Salt Mixtures" for Tissue Culture to Which are Added Coaolex Coabined Nutrients of Carbohydrates, Vitaains, taino Acids and Organic Acids as in Eagle's Basal Media ( Eagle HJ. J Bicj. Chra 214, 639, 195.) which is Added to Earle's Salt Mixture. (10) (22) (23) (24) (25) (26) (26a> (11) Units Noraal Krebs Earle's UilliaaVs Hank's Haa's Delbecco's Delbecco's Krebs Plasaa Henseleit Balanced Salts F-12 Phosphate Modified Ringer ■aoles N * £•J * π * Salts Saline Eagle's Phosphi • ' " .,0 283, 12B5 L fluid 1970 J Na 136 - 145 143 142 144.3 142.8 146.9 152.2 154.5 150.76 K 3.5 - 5.0 5.9 5.4 5.4 5.6 10 4.17 5.4 5.92 Ca 2.1 -2.6 2.5 l.β l.βl 1.3 0.3 0.9 l.β 2.54 V) free [Ca2+] I 1.06- 3 lι-i) 0.75-1.25 1.2 0.8 0.61 0.8 0.6- 0.49 0.β 1.16 free [Hg2- [ 0.53 1 ,HS InEq Cations 142.7-153.2156.3 152.6 154.9 152.6- 151.7 159.15 165.1 164.12 Cl 100 - 106 127.6 126.2 126 146 133.6 140.5 118.5 131.51 HCO3 26-26 25 23.6 26 4.17 14 - 44 - I Pi 1 - 1.45 l.lβ 1 1 O.β 1 9.Θ3 1 17.36 SO* 0.32-0.94 l.lβ o.e o.β O.β 0.6 0.46 0.6 1.IB L - lactate 0.6 - i.e pyruvate 0.23 0.9 1.0 Lact/pyr 0 0 0 Other E_£q anions 12β.7-139.4157.3 153.4 155.7 152.9 151.5 159.IB 166.1 163.97 Na/Cl 1.28-1.451.12 1.12 1.15 0.975 1.10 1.08 1.30 1.15 m βlucose 3.9-5.6 - 5.6 11.1 5.6 10 - 25 - or others C02 0.99-1.391.24 1.24 1.24 - 1.24 - 1.24 - PH 7.35-7.457.4 7.4 7.4 S7.6 7.1 7.4 7.65 7.4 la-fea 285-295308 311 321 308.2 312 308 354 311.7 i-i Use: Tissue Saae as Tissue Tissue Tissue Tissue ( Culture 22 culture- Culture Culture Culture *.0. ^ ..... Salts to aunipu- i ' -'_ Hhich lation. nutrients xxrt added 10) It can be seen that Earle's Balanced Salts and "Uilliaas* are just Krebs-Henseleit aith Kg and Ca decreased to aore phsiological levels. Both use HCO3/CD2. Both lack the proper NaCl ratio. 22 ) Earle UR. et al. I NatM Cane Jnst 4, 165-212, 1943. Used with 5* ∞£ and 2W 0_. 23 ) Uilliaas 6M et al. Exfl CeH Res 69, 106-112, 1971. 24 ) Hanks JH, W llace RE. Prgc Soc ____> Bii Med 71, 1961949. For use outside COg incubators. 25 ) Haa RG. Proc ______l Acad Sci __ S_.53, 2ββ, 1965. Analogous to Tyrode's ( 9) Table I. HCO3 deficient. 26 ) Delbecco R, Vogt M. J Exfi Med 22, 167-162, 1954. Si ily Krebs Ringer Phosphate with lowered Ca and Mg. The 1 gh Pi would lower cellular KATP./IΣADPHEPi]. 26a ) Delbecco R. Virology 8, 3%, 1959. Lacks redox bal ce as does (22) and (25). The pH is high for general > . -8- Comte porarily, a large n-umber of different aqueous electrolyte solutions or their salt concentrates are prepared sold in commerce, and used in in vitro fluids, principally as tissue culture fluid media. Even a cursory examination of Table I will confirm the medical dicta that "plasma is an unma able solution". The solutions listed in Table I illustrate this belief. The essential problem is that plasma contains, in addition to major inorganic electrolytes, trace quantities of various electrolytes plus various metabolites including plasma proteins. In practice, it has not been possible to construct synthetically a replication of plasma extracellular fluid or intracellular fluid because of their complexity. Blood, extracellular and intracellular fluid, and even plasma can be regarded as tissues. In most prior art electrolyte solutions, the concentration of chloride anions (Cl~) is higher than in human plasma or serum. For example, the Krebs-Henseleit solution (see Table I) contains a concentration of Cl which is about 20% higher than in fluids such as plasma. This anion gap, that is, the difference between the posititve cations and the negative anions, is now known to be due largely to the anionic metabolites such fluids plus the contribution of acidic a ino acid groups found on plasma proteins. Referring to Table I, it is seen that the total positive cations in, for example, human plasma is 142-154 meq/1 while the total anions is only about 128-137 meq/1 leaving a deficit of about 14-17 meq/1 of anions. For convenience, the anion gap in such fluids can be expressed as the ratio of sodium cation milli- equivalents per liter to chloride anion milliequivalents per liter. From Table I, it is clear that the Kreb's Serum substitute (Kreb's, H.A. Biochem. Biophys. Acta 4, 249-269, 1950) comes closes to approximating the electrolyte composition of such fluids. In this solution, Krebs <§si ET -9- attempted to correct the excessive Cl~ " content in Krebs Henseleit solution (Hoppe.Z.Physiol. Chem. 210, 33-66, 1932) using metabolic experiments with tissue slices. Because cf the law of electrical neutrality, Na cannot be added to a solution without some anion (such as Cl ) being added also; the sum of cations and anions must be equal in any solution. In his 1950 attempt, Krebs chose pyruvate " , L-glutamate , and fumarate as anions to be added. The alternative to Krebs-Henseleit is essentially Krebs-Ringers Phosphate or Delbecco's tissue culture media where Pi is present in amounts about 10 to 25 times normal plasma concentrations. Such media are used so as to eliminate HC0 3 ~/C0 2 . Both such solutions, used respectively in perfusion or cell culture not only have too high Pi which induces an abnormal intracellular [ΣATP]/[∑ADP]/ [ΣPi] ratio but also have too low a Na:Cl ratio inducing hyperchloremic acidosis. The alternate use of lactate or pyruvate alone induces severe abnormalities in cellular redox state and phosphorylation potential. The use of gluconate induces abnormalities in the nexosemonophosphate pathway. Indeed, all previously used organin ions violate the "safe entry points" or the normal Na:Cl ratio as herein defined. In addition to the use of lactate, gluconate, fumarate, glutamate, pyruvate, and citrate anions in current commercially available prior art electrolyte fluids, and wherein such anions are typically employed at levels above those found in the (plasma or serum) of healthy humans, many such prior art commercial fluids also employ high levels of nonionic metabolites, such as fructose and glycerol, which induce separate redox state and phosphorylation potential abnormalities of their own. Thus, fructose causes severe abnormalities in phosphory- lation potential with rapid destruction of liver purine nucleotides and their release into blood sometimes leading to renal shutdown due to uric acid deposition in the •si -10- kidneys ( see Woods, H.F., Eggleston, L.V., and Krebs, H.A. Biochem. J. 119, 501-510, 1970) . Fructose in plasma above 0.2mM must be considered to violate the "safe entry point". Likewise, use of intravenous glycerol at levels above 5m /l as currently practiced leads, in tissue containing glycerol kinase, such as kidney and liver, to accumulation of lOmM glycerol phosphate (over 100 times normal) . (See Burch, H.B. et al. J. Biol. Chem. 257, 3676-3679, 1982). Mammalian systems normally operate at temperatures between about 37-38°C whereas, by common thermodynamic convention, neutral pH is taken to be about 7 at 25°C. It is clear that changes in pH, (the negative log, Q of [H ] concentration) necessarily affect the fundamental energetic relationships occurring in living cells. Also, enzymes have sharply defined ranges of [H ] concentration in which they perform their catalytic functions in a normal manner. Deviation of mammalian plasma pH down to 6.9 or above 7.7 from its normal range of 7.35-7.45 is v therefore fatal to most mammalian organisms. Massive changes in the cellular redox and phosphorylation states also disorder cellular homeostasis. The pH of human plasma is normally maintained by the human body in the range from about 7.35 to 7.45 while the pH of human cellular cytoplasm is about 7.2 (see Veech et al. in J. Biol. Chem. 254, 6538-6547, 1979). If blood pH drops to 6.8 in man, then death ensues from cardiac arrest, and if blood pH increases to above pH 7.7, then death ensues from convulsions. The major chemical system maintaining body pH within this narrow normal range is- the [CO_]/[HCO,~] buffer system. The [CO-] of blood is maintained minute to minute by a portion of the mammalian brain called the respiratory center which senses brain cell pH and adjusts the depth and speed of respiration in response to changes in pH by increasing or decreasing [C0 2 ] according to the famous Henderson Hasselbalch equation (Henderson, L.J. , Silliman Lectures Yale U. Press, New Haven, 1928). SUBSTIT -11- Even though pH is thus seen to be a critical factor in mammalian blood, many commercial electrolyte solutions used in vitro attempt to maintain pH with phosphate or even artificia?. buffers such as Tris and the like. The absence of C0 2 /HC(_ ~ necessarily induce profound changes in the [NADP ]/[NADPH] redox state but in all the metabolites of glycolysis (see Miller, A.L. et al. J. Neurochem. 25, 553-558, 1975). The compositions and methods of the present inven- tion overcome the above indicated prior art problems. These compositions and methods employ definite ratios of [bicarbonate "" ]/[carbon dioxide], [1-lactate ]/[pyruvate ], and [d-betahydroxybutyrate~]/[acetoacetate ]. Each of these mixtures constitute a near equilibrium couple which is known to be a normal constituent of mammalian plasma. While each of these pairs of components has been previously employed at least on a laboratory basis in solutions used for animal (mammalian) experiments, these mixture pairs have never previously been used in an electrolyte solution to obtain a normal Na:Cl milli¬ equivalent ratio or to solve the anion gap problem. All previous electrolyte solutions, and plasma substitutes, induce severe and measurable pathogenic abnormalities and no prior art electrolyte solution or plasma substitute has both (a) employed at least one of the three mixture pairs of this invention and (b) achieved a normal Na:Cl milliequivalent ratio as taught herein. Thus, for example, the Krebs-Henseleit solution contains the [HC0 3 ]/[CC * 2 ] buffer system (but contains excessive chloride ions) . Schimassek (Schimassek, H. Bio. Chem. Z_. 336, 460, 1963) added about normal blood levels of lactate and pyruvate to what is essentially Tyrode's solution (see Tyrode, M.J. Arch. Int. Pharmacodyn 20, 205, 1910) containing a 2.5% albumin in an attempt to create a physiological solution for perfusion. It should be noted that Schimassek added 1.33 mM/L D-L-lactate, which is definitely abnormal (see normal blood lactate levels SUBSTITUTE SHEET -12- shown in Table I). Further, the Na of 151 mM/1 and Cl " of 147.5 mM/1 in Schimassek's modified Tyrode's solution approximates the concentration of 155 mM/1 Na and 155 mM/1 Cl in so-called normal (0.9%) saline, the most widely used electrolyte infusion solution, and thus obtained a grossly abnormal Na:Cl milliequivalent ratio of 1.00. Normal plasma has a Na:Cl milliequivalent ratio of about 1.24-1.45 with a mean of about 1.38. Infusions of electrolyte solutions with a Na.Cl milliequivalent ratio of less than about 1.38 have long been known to cause hyperchloremic acidosis in the treated organism. (See Levinsky, N.G. in Harrison's Textbook of Medicine pp. 230-236, McGraw-Hill, N.Y., 1983). It is the attempt to avoid this problem that leads to the wide use of such solutions as Ringer's lactate or acetate dialysis fluids which overcome the Na:Cl ratio problem, but which in turn create gross abnormalities of other types. It is the attainment of a normal Na:Cl milliequivalent ratio in a manner which avoids the pathological consequences in herent in all currently known or practiced methods which is a major part of the invention herein disclosed. The making of a Krebs-Henseleit electrolyte solution (or other prior art electrolyte solution) and the incorporation there into of a mixture of 1-lactate and pyruvate anions, or of a mixture of d-betahydroxybutyrate and acetoacetate anions did not, and could not, result in the making of an electrolyte solution wherein the anion gap problem was overcome (or wherein the milli¬ equivalent ratio of sodium cations to chloride anions was normalized) , in accordance with the teachings of the present invention, because each of such resulting solutions would still contain excessive chloride anions and so would inevitably cause hyperchloremia if and when used under in vitro use conditions. V M " fcSTlTUTS SHEET -13- In general summary, the prior art describes a series of electrolyte solutions typically of about 270- 320 milliosmoles (or higher) comprised of: (a) 1 to 4 metallic cations of sodium, potassium, magnesium, and calcium in amounts greater than 0.5 mM/L, (b) 1 to 5 2- 1- inorganic anions of chloride plus also H 2 PO. HPO. (the later also called Pi herein) , sulphate (SO. ) , (c) 0 to several organic carboxylic or bicarbonate anions, (d) 0 to about 12 nonionic materials in concentra- tions of greater than about 0.5 mM/L from the group comprising C0 2 gas, glucose, urea, glutamine, and others, and (e) sometimes one or more high molecular weight substances, such as albumin, hemocel, and the like. None of these solutions, for the reasons herein above explained, either normalize the milliequivalent ratio of Na:Cl at all, or normalize this ratio without causing profound and adverse physiological consequences. In the present invention, there are provided processes and compositions of a complex fluid nature for n vitro usage which can substantially completely eliminate all of such prior art problems. While the components of these new solution compositions are known solution components, no one has heretofore formulated the solutions of the present invention which not only tend to achieve a normal plasma milliequivalent ratio of sodium cations to chloride anions, but also tend to achieve a normalization of plasma pH and a normalization of the cellular redox state and the cellular phosphorylation potential. Also, these new solutions permit one to avoid usage of the previously employed carboxylic anions, such as acetate, or lactate alone, which cause adverse effects. BRIEF SUMMARY OF THE INVENTION This invention relates in one aspect to improved in vitro processes for accomplishing tissue culture perfusion and/or incubation of living animal cells, groups of cells, or organs, by contacting such cells with an aqueous solution wherein: _. _ _-- - ---} -' _ iTP' ^H t -14- (a) the ratio of sodium cation milliequivalents per liter to the chloride anion milli¬ equivalents per liter are so selected as to tend to produce the range found in normal . -" animal intracellular fluid, and (b) there is a physiologically effective amount of at least one near-equilibrium couple selected from the group consisting of - (1) bicarbonate and carbon dioxide, (2) l-lactate~ and pyruvate , and (3) d-betahydroxybutyrate " and acetoacetate ' and (c) the pH ranges from about 6.9 to 7.8. This invention further relates to physiologically compatible aqueous electrolyte salt solutions for tissue culture or contacting animal mammalian cells in vitro in any manner, which solutions contain such a ratio of sodium to chloride and which solutions incorporate at least one such near-equilibrium couple within the ranges specified to so acheive said specified Na:Cl ratio. This invention provides electrolytes of the class indicated wherein physiologically normal concentrations of the divalent cations Mq 2+ and Ca2+ may be included without precipitation. When used for contacting mammalian or avian cells or organs in accord with the present process teachings, such a solution generally: (a) tends to maintain the intracellular milli¬ equivalent ratio of sodium cations to chloride anions in a normal range, and (b) tends to normalize intracellular pH and/or tends to normalize the cellular redox state and the cellular phosphorylation potential. In such in vitro applications as cell (including organs, embryos, and the like) perfusion, cell incubation, or the in vitro preservation of cells or of whole organs, as those skilled in this art will readily appreciate, it ≤ -F -15- is possible to use the electrolyte solution of this invention as such for contacting purposes. In other such applications, the electrolyte solutions of this invention are typically used in combination with nutrients in the quantity generally of the types known and heretofore used in this art, as those skilled in this will readily appreciate. One (first) class of such solutions characteristi¬ cally utilizes (contains) an inorganic class of anions comprised of chloride and bicarbonate. These solutions have a physiological pH which is broadly in the range from about 5 to 9, and preferably in the range from about 6.9 to 8.6, and mroe preferably in the range from about 7.35 to 7.45, and most preferable is about 7.4. hen HC0 3 ~ is present, dissolved carbon dioxide must be present in these solutions C0 2 must also be present in the amounts specified so as to achieve the pH desired. When used, these solutions not only tend to maintain a normal Na:Cl ratio in the surrounding fluid media, but also tend to set (regulate) the treated cell's internal (e.g., intracellular fluid) pH within normal limits of about 7.35 to 7.55. Another (second) class (preferred) of such solutions characteristically, utilized (contains) chloride anions and a class of carboxylate anionic couples comprised of at least one pair from the group consisting of (a) a mixture of 1-lactate anions and pyruvate anions, (b) a mixture of d-betahydroxybutyrate " anions and acetoacetate " anions, and (c) a mixture of both (a) and (b) . These solutions have a physiological pH which is as above defined in connection with such (first) class of solutions. When administered, these solutions not only tend to maintain the treated cells redox state within a normal range, but also tend to maintain that cells phosphoryla- tion potential within a normal range. ..→, * -~-r~ G- ' -. i : : , ' _ -4t ST-i_-~c___~*T -16- Another (third) class (more preferred) of such solutions characteristically uT±iized (contains) both chloride anions, and bicarbonate/carbon dioxide mixture, as in such (first) class of solutions, but also utilizes (contains) such ^ class of carboxylate anionic couples, as in such (second) class of solutions. When administered, these solutions achieve the above indicated effects obtained from the use of such (first) class of solutions and the above indicated effects obtained from the use of use (second) class of solutions. The specified milliequivalent ratio of sodium to chloride in normal mammalian blood generally is believed to be in the range from about 1.28:1 to 1.45:1. Broader ranges of ratios centering around these ratios are employed in solutions used in the practices of this invention although marked deviations from the normal ranges may also be used to achieve special purposes. The total quantity, or sum(sigma) , of bicarbonate anions and carbon dioxide present in a solution of this invention ranges from 0 to 55 millimoles per liter of solution. The ratio of bicarbonate milliequivalents per liter of solution. The ratio of bicarbonate milliequi¬ valents per liter to dissolved carbon dioxide milliequi¬ valents per liter in a solution of this invention can range from about 6.3:1 to 55:1.1. Preferably, bicarbonate concentration ranges from about 20 to 50 mM/1 and such ratio ranges from about 10:1 to 32:1, and more preferably such total ranges from about 23 to 35 mM/1 while such ratio ranges from about 19:1 to 21:1. A ratio of 19.95 for [HC0 3 ~]/[C0 2 ] gives a pH 7.4 which is presently par¬ ticularly preferred. The total quantity, or sum (sigma) of l-lactate anions and pyruvate anions present in a solution of this invention ranges from 0 to 55 millimoles per liter of solution. The ratio of L-lactate anion milliequivalents per liter to pyruvate anion milliequivalents per liter in a solution of this invention can range from about 30:1 to 1:1. Preferably, such total luantity ranges from ι~'-4~ ~'—"'~ -17- about 0.5 to 10 mM/1 and such ratio ranges from about 3:1 to 15:1, and more preferably such total quantity ranges from about 2 to 8 mM/1 while—such, ratio ranges from about 5:1 to 12:1. _ - —" The total quantity, or sum (sigma) of d-betahy¬ droxybutyrate anions and acetoacetate anions present in a solutions of this invention ranges from about o to about 55 millimoles per liter of solution. The ratio of D-betahydroxybutyrate anion milliequivalents per liter to acetoacetate milliequivalents per liter in a solution of this invention can range from about 6:1 to 0.5:1. Preferably, such total ranges from about 0.5 to 10 mM/1 and such ratio ranges from about 4:1 to 1:1, and more preferably such total ranges from about 2 to 5mM/l while such ratio ranges from about 3:1 to 1.5:1. By the term "milliequivalent ratio" as sometimes used herein, reference is made to the ratio of milli¬ equivalents per liter of one substance to milliequivalents per liter of another substance in an aqueous medium. One of the three near-equilibrium couples employed in the practice of this invention (the bicarbonate / carbon dioxide couple) generally tends, as used in this invention, to regulate the concentratio- of hydrogen ions in the bathing media and in treated cells, and each one of such couples generally tends to normalize the redox state of each of the three pyridine nucleotide couples. The phosphorylation potential also generally tends to be normalized. Also, each such near-equilibrium couple when used as herein described constitutes a safe entry point into the netabolic system of a treated cell. By the term "safe entry point" as used herein reference is generally had to a metabolite which, in living tissue or cells: (1) does not cause a massive build up of one or more of intermediate cellular metabolites. SUBSTITUTE SHEET -18- (2) does not cause a severe disruption of any one of the controlling nucleotide ratios in a living cell, (3) can be added to a physiological system of a living mammal at a concentration level which is greater than that which is found normally in resting, overnight fasted normal man (such as blood plasma of ' a fasting mammal) without causing appreciable distortion in metabolism and without causing appreciable pathological conditions to arise, and (4) may be found in normal variants of the physiological state as when the total of D-betahydroxybutyrate plus acetoacetate reaches a level of about 7 to 10 mM/1 in three-day fasting man, or the total of L-lactate plus pyruvate rises to a level of about 5 to 6 mM/1 in a normal jogging man. Further, each such above described near-equilibrium couples in this invention exhibits a distribution or permeability between intracellular fluid and extracellular fluid such taht the ratio of the concentrations in, respectively, intracellular fluid to extracellular fluid ranges from about 1.0:1 to 1.5:1 in most all mammalian cells. Nonionics incorporated with the solutions of this invention preferably should each constitute a safe entry point. For example, glucose above 13 mM/1 is higher than ever occurs under normal physiological conditions in a healthy man. Use of a glucose above 13 mM/1 (as in the widely used 5% glucose solution) as a calorie cource is, apart from consideration of the source of pathology, and apart from the carboxylate couples, considered herein to be an acceptable source of calories. The extreme ability of the mammalian body to regulate of glucose metabolism makes it far to be preferred over other possible nonionics, such as fructose or glycerol, which enter the metabolic system in an un-controlled manner causing -19- pathologic changes such is already referenced, and so such are not safe entry points. In the special cases where tissue water may need to be removed, as in the case of cryo-preservation of tissues, very high concentrations of osmotically active substances may be used. Characteristically, a solution used in the practice of this invention contains from about 130 to 170 millimoles per liter of sodium cations, and more preferably from about 129 to 163.5 mM/1 and most preferably from about 136 to 155 mM/1. In addition, a solution contains suffi¬ cient chloride anions to produce a milliequivalent ratio of sodium cations to chloride anions in the range above defined. Optionally, in addition to sodium, a solution of this invention contains at least two of the following additional metallic cations each in a respective quantity as below indicated: Quantity range cation (millimoles per liter) component broad preferred potassium 0 - 40 1 - 5 calcium 0 - 10 0.2 - 1.5 magnesium 0 - 10 0.2 - 1 Optionally a solution of this invention can have additionally incorporated (dissolved) therein from 0 to about 6000 millimoles per liter of at least one substan¬ tially nonionic (including zwitterionic) osmotically active substance (which is preferably metabolizable) . A solution used in the practice of this invention is further characterized by generally having (1) sufficient total substances dissolved therein to produce an osmolarity ranging from about 260 to.6400 milliosmoles (mOs) , and prefer- ably from about 265 to 550 Os, and most preferably from about 280 to 320 in mOs; ~"i ~~ ι — •"-• - *—>. . an. -. w w^ J u ϋTE SHEET -20- (2) the relationship between total (dissolved) substances is such that the pH ranges from about 6.8 to 7.8; and most preferably from about 7.35 to 7.55; — * ' (3) the charges of all cations equal the charges of all anions, and (4) the minimum total concentration of all such near-equilibrium couple(s) present is at least about 0.1 millimoles per liter, and preferably is at least about 0.5 mM/1, and more preferably about 2 mM/1, while the maximum concentration thereof is preferably not more than about 80 and more preferably is not more than 61 raM/1 and most preferably is not more than about 50 mM/1. Examples of usable such nonionic substances include glucose, glycerol, fructose, sorbitol, urea and the like. Glucose is presently most preferred for nutrional purposes, and glycerol presently most preferred for cryopreservation purposes. Also optionally a solution of this invention may have incorporated in it from 0 to 55 mEq/liter of a polyanion incorporated in it, preferably in the Na form. As hereinbelow explained, the processes and the solutions of the present invention find use in a wide variety of in vitro uses, such as "balanced salt solutions" (see Table III) to which nutrient mixtures may be added, perfusion fluids for organs, perfusion fluids containing substances like glycerol or urea for cytopreservation of organs, cell incubation experiments, and the like. Various additional objects, aims, purposes, features, advantages, application, variations, and the like will be apparent to those skilled in the art from the teachings of the present specification taken with the claims. w-'~-~- - -~=- ~-m HEET -21- DETAILED DESCRIPTION This description is based upon best available information (including theory) known to the inventor. Any misdescription or the like, if such should exist, is not believed to alter the fundamentally correct basis and evidence supporting the present invention. A. The Redox State In biological cells, most reactants are catalyzed by enzymes of which an average cell may have of the order of 10 4. In one classification, enzymes may be grouped in only six major functional categories: (1) dehydrogenases which transfer H and e~ from one substrate to another by the use of co- factors, such as NAD (nicotina ide adenine dinucleotide) , or prosthetic groups, such as FAD ( flavin adenine dinucleotide), or others; (2) kinases or phosphotransferases which effect the group transfer of a phosphate to a sub¬ strate usually by using a co-factor, such as ATP or other similar phosphate-containing compounds; (3) carbon-carbon bond group transferases which either make or break carbond-carbon bonds using co-factors of the coenzy e type or occur on a solid state matrix, such as the glycogen particle, or the surface of a fatty acid synthases multi-enzyme complex; (4) isomerases which effect internal rearrange¬ ments within a compound; (5) hydratases which either add or subtract water from a substrate; and (6) peptidases which break C-N bonds or create such bonds again usually taking advantage of a solid state synthetic matrix, such as a ribosome. fi&B8T1TUTE SHEET -22- A special class of substrates taking part of biological reactions catalyzed by enzymes are called co-factors or co-enzymes. Co-enzymes, such as, for example, NAD, become attached and detached from an enzyme during a catalytic cycle, while prosthetic groups, such a flavin nucleotides or cytochromes, remain firmly attached during the catalytic cycle. Since co-enzymes take part in multiple intracellular reaction within a given cellular compartment, the chemical portential of the co-enzyme couple becomes of central imporatnce in energy transformation and oxido-reductions occurring in living matter. The thermodynamic character¬ istics of a particular whole set of oxido-reduction reactions is dependent upon the ratio of the free con- centrations (strictly speaking, the activities) of the free [NAD ] and free [NADH] ratio. The ratio [NA(P)D ]/[NAD(P)H], thus represents and defines the redox state, at a given pH, of a particular pyridine nucleotide couple, and this ratio then determines: (1) the extent and direction of reversible reactions in near-equilibrium with that co-enzyme couple; (2) the extent to which a co-enzyme couple can be effective as an intracellular reducing agent, for example, in reducing the beta- oxoacyl co-enzyme A to beta-hydroxyacyl- ■ . co-enzyme A; and (3) the magnitude of the free energy changes of oxido-reductions in the electron transport chain responsible for the major portion of ATP synthesis. The term "redox state" as thus used herein can be considered to refer to the oxidation-reduction state of any one or more of the three main pyridine nucleotide couples. Each of these couples are: 5 < ___s_3Ϊ3ϋ-» ! -_ _ . i → J SHEET -23- (A) The cytoplasmic [NAD + ]/[NADH] linked dehydrogenase reactions of: (1) l-lactate dehydrogenase (EC 1.1.1.27); (2) Malate dehydrogenase (EC 1.1.1.37); and (3) Glycerol- 3-phosphate Dehydrogenase (EC 1.1.1.8). (B) The mitochondrial [NAD + ]/[NADH] linked dehydrogenase reactions of: (1) d-Beta- hydroxybutyrate dehydrogenase (EC 1.1.1.30); and (2) Glutamate dehydrogenase (EC 1.4.1.3). (C) The cytoplasmic [NADP + ]/[NADPH] linked dehydrogenase reaction of: (1) 1 - Isocitrate dehydrogenase (EC 1.1.1.42); (2) 6-Phospho- gluconate dehydrogenase (EC 1.1.1.44); and (3) the Malic Enzyme (EC 1.1.1.40). The three pyridine nucleotide couples or pools each achieve different redox potentials because of the chemical energies of the substrates to which they are linked by their respective enzymes since the standard redox potential of [NAD + ]/[NADH] is about -0.32 V. Thus, the near- equilibrium NAD- linked dehydrogenases have a Keq of about 10 M, the mitochondrial NAD-1inked dehydrogenases have a Keq of about 10 -9M, and the cytoplasmic NADP linked dehydrogenases have a K of about 1. The difference in pyridine nucleotide redox states within the cell may be considered to result from the fundamental properties of matter. Over time, enzymes have evolved which take ' advantage of these fundamental properties to organize the chemical reactions of the cell into coherent purpose¬ ful sequences we know as metabolism. The oxidation of l-lactate anions to pyruvate anions (that is, the lose of 2H and 2e~ from lactate) is accompanied by the reduction of pyridine nucleotide NAD . That is, NAD gains two electrons and one H being liberated into the aqueous media where its activity is indicated and controlled by the HC0 3 ~/C0 2 couple. "." 5- T JTUTE SHEET -24- In general, the term "redox state" may also be defined as a ratio of [oxidized substrate]/[reduced substrate] . The half or mid point potential E h is conventionally measured as a potencial in volts relative to a standard hydrogen electrode potential in accordance with the Nernst equation. The mid-point potential of the NAD + system, that is, where the ratio of [NAD ]/[NADH] equals 1 at a pH of 7.0 and a temperature of 25°C, is -0.32 volts under standard conditions. The cytoplasmic pyridine nucleotide system accepts H and e from the organic compounds provided to mammalian organisms and transfers them to the mitochondrial pyridine nucleotide system where, by the electron transfer system, the 2H + 2e reduce 1/2 0 2 to form water while conserving the energy of the oxidation reduction reaction by converting ADP + Pi to ATP. The reaction generates energy and heat. The redox state of cytoplasmic [NAD ]/[NADH] couple is about -0.19 volts, that of the mitochondrial [NAD + ]/[NADH] couple is about -0.28 volts while that of the cytoplasmic [NADP + ]/[NADPH] couple is about -0.42 volts. The last or NADP couple is a much stronger reducing agent than the others and is used for reductive synthesis in the body, such as the making of fatty acids from carbohydrates; (see Krebs and Veech, 1969) in The Energy Levels and Metabolic Control in Mitochondria (Papa, S., Tayer, J.R., Quagliariello, E. & Slater, E.C., eds) pp 329-382, Adriatica Edrice, Bari. In the case of a living cell, a plurality of oxidation-reduction reactions occur simultaneously. Under normal conditions, these reactions occur in a normal healthy cell in a predictable manner. How these various redox states are regulated has just been described in thermody- namic terms. The normal healthy cell keeps the redox state of its free cytoplasmic [NAD + ]/[NADH] redox couple at a ratio of about 500 to 1500 which corresponds to a voltage of about -0.2 volts. In this way, the cytoplasmic l " - ' St*7U7_ SHEET -25- + pyridine nucleotides can accept the H and e from the substrates or food presented into energy. When the cell is metabolizing very reduced substrates, such as fatty acids, the cytoplasmic [NAD + ]/[NADH] is about 400-800. When the cell is metabolizing carbohydrates or amino acids, it is obvious that these compounds are already partially oxidized. Therefore, the free cytoplasmic [NAD + ]/[NADH] reflects the oxidation level of its sub¬ strate and becomes more oxidized in the range of about 800 to 1500. The redox state of the free cytoplasmic [NAD ]/ [NADH] couple can be determined by various techniques, such as by measuring the ratio of [l-lactate ]/[pyruvate ] (a) in freeze clamped tissue, (b) in the venous effluent leaving the organ in question, or (c) in the medium bathing the tissue in question. Alternatively [1-malate ]/ [oxaloacetate " ] of [α-glyerophosphate/dihydroxyacetone-P] ratios in tissue may be measured, if desired. The value of cytoplasmic [NAD ]/[NADH] can then be calculated. In healthy living mammals, the ratio of [l-lactate ]/ [pyruvate ] is about 6, but can range, under special situations, such as starvation, to about 15-20. A [l-lactate ]/[pyruvate ] ratio below about 20, as occurs after ethanol consumption because of its links to the cytoplasmic [NAD ]/[NADH], is pathologic. A character¬ istic in all cells having a low [NAD ]/[NADH] ratio is believed to be demonstrable (observable) pathologic consequences, such as tissue swelling, low phosphorylation potential, low plasma membrane voltage, and abnormal electrolyte distribution between intracellular and extracellular H 2 0. Similarly, the redox state of the free mitochondrial [NAD ]/[NADH] can be determined by various techniques using tissues such as, for example, kidney or liver, by measuring the ratio of [d-beta-hydroxybut rate~]/ [acetoacetate " ] (a) in freeze-clamped tissue, (b) in the venous effluent leaving such tissue, or (c) in the fluid bathing isolated such tissues. A determintion of the free _*•-•« —**- TUTE SHEET -26- mitochondrial [NAD ]/[NADH] in other tissues, such as brain or heart muscle, is more complex, but, in some cases, can be accomplished by measurement in freeze clamped tissue of the [alpha-keto glutarate " ] [NH 4 ]/ [glutamate " ] ratio (see Miller A.L. , Hawkins, R.A. , and Veech, R.L. J. Neuroche . 20, 1393-1400, 1973). The normal ratio of mitochondrial [NAD ]/[N. is between about 5 and 20, and the normal ratio of [beta-hydroxybutyrate ]/[acetoacetate ] is about 1.3 to 55.. TThhee vvaalliue of mitochondrial [NAD ]/[NADH] can then be calculated. The redox state of the free cytoplasmic [NADP ]/ [NADPH] couple is, of course, affected by the [C0 2 ] of surrounding fluids. Because of the lack of substrates which are permeant to the cell wall without significant and variable gradients, this redox state cannot at pre¬ sent be directly and totally regulated other than by the intracellular metabolic links with the cytoplasmic and mitochondrial [NAD ]/[NADH] . (.See Krebs H.A. and Veech, R.L. "Pyridine Nucleotide Interrelations", 1969 in The Energy Level and Metabolic Control in Mitochondrial in Papa, S., Tager, J.M., Quagliariello, E. , and Slater, E.S., EDS, pp 329-383., Adriatica Editrice, Bari) . Thus, for instance, because pyruvate reacts in both cytoplasmic [NAD + ]/[NADH] and [NADP*]/[NADPH] , administration of [HCO " ]/[C0 2 ] and [l-lactate~] [pyruvate " ] within certain narrow limits regulates these ratios because: [NAD„c + ] [NADPc J x Kmal .i .c Λ enzyme x [malate 2" ] [NADH c ] [NADPH C ] K LDH [l-lactate " ] [C0 2 ] Pyruvate " , l-lactate " and C0 2 are permeable to cell wall in a simple fashion, as are d-betahydroxybutyrate " and acetoacetate -, while malate2- and other dicarboxylates are not. -27- While the importance of redox state to the main¬ tenance and normalization of intracellular metabolic porcesses and bioenergetics has long been recognized, there has never been previously so far as is now known any attempt to regulate or to normalize the redox state in cells being manipulated in_ vitro using electrolyte solutions which contain a normal Na:Cl ratio. The present invention provides compositions and methods for regulating and/or normalizing the redox state in cells or portions of organs or whole organs or whole organisms being manipulated or grown in vitro. Exisiting electrolyte fluids make no attempt to maintain or normalize cellular redox potentials in any way whatsoever. In fact, most existing electrolyte fluids for in vitro use actually severely distort or make abnor¬ mal the redox balance of the cells, resulting in multiple and definable abnormalities. In this way, exisiting electrolyte fluids distort such things as, for examples, the rate of fat oxidation, the rate of glucose production, the rate of uric acid excretion, the rate of galactose metabolism and the like. All of these abnormalities lead to, pathological consequences of a definable type such as, for example, in liver. D. The Phosphorylation Potential. Just as the [NAD + ]/[NADH] ratio is defined as a "redox state", by analogy, it is customary to define the energy state of the adenine nucleotide co-enzyme couple as the "phosphorylation state" or the "phosphorylation potential". Because in living cells ATP, ADP, and HPO. exist in several charged forms, and in various complex- ation states with Mg 2+, it is customary to define these forms as sigma ATP, sigma ADP, and sigma Pi. The phosphorylation potential is thus defined by the relation¬ ship [sigma ATP]/[sigma ADP] [sigma Pi], SUBSTITUTE SHEET -28- 1 It is clear that the reaction of oxidative phosphorylation contains both the redox state of mitochondria dn the cytoplasmic phosphorylation potential. While the phosphorylation potential cannot apparently 5 be controlled by addition of ATP or ADP to the media surrounding cells because these compounds are impermeant to ce-1 wall directly. There is, however, another reaction which is in near-equilibrium with the cytoplasmic [sigma ATP]/[sigma ADP] [sigma Pi] (see Veech et al. in 10 J. Biol. Chem. 254, 6538-6547, 1979). This reaction involves the two most active enzymes in the glycolytic sequence found in nearly all living cells and catalyzed by the enzymes glyceraldehyde 3-phosphate dehydrogenase (EC 1.1.1.29) and 3-phosphoglycerate kinase (EC 2.7.2.3). 15 Veech et al. (reference just cited) provide an equation which defines the relationship between the free cytoplasmic phosphorylation state of [sigma ATP]/[sigma ADP] [sigma Pi]. This relationship is now and accepted by those familiar with this art and is (equation 5) : 20 [sigma3PG] [sigmaATP] [NADH] [H + ] K = . - = 1.83 x 10~ 4 [sigmaGAP] [sigmaADP] [aig a Pi] [NAD ] K G+ G [sigma3PG] [sigmaATP] . [lactate] 25 K LDH [sigmaDHAP]/22 [sigmaADP] [sig aPi] [pyruvate] 1.65 x lO^ "1 Metabolism in any living cell may be considered to be an ordered process whereby [H ] and electrons [e~] are removed from substrates and passed to co-enzyme _- acceptors which are largely cytoplasmic NAD . This co- factor thus has a potential in the cell far more oxidized at about -0.19 volts than its standard potential of about -0.32 volts so that it may accept these electrons. The H and e gathered in the cytoplasm, or even created in 3 _ the mitochondria, may then be transferred to mitochondria by mechanisms involving other substrates linked to mitochondrial [NAD ]/[NADH], which has a lower potential of about -0.28 volts in most mammalian cells. If e " and -29- H + are produced with a higher voltage, such as for example, from the oxidation of succinate or fatty acids, they form reduce FADH2 from FAD which has a more oxidized potential and therefore less potential energy. H and electrons produced from NADH-linked substrates produce 3 ATP for each 1/2 0 2 consumed while those from flavo-protein (FAD) acceptors produce only 2. This difference in energy is due to the fundamental difference in the chemical reactions involved in producing the H and e . The fundamental process of cell respiration where NADH is oxidized to form heat and energy is called oxidative phosphorylation. It occurs in cellular organ- elles called mitochondria in a series of redox reactions called the electron transport chain. The mitochondrial electron transport system takes two electrons [2e ] from substrates and passed them up the chain to reduce 1/2 0 2 forming H 2 0. The energy realized in this process is conserved in the cell in a chemical form of the anhydride bond in the terminal phosphate group of adenosine triphos- phate (ATP) . The formation of three phrophosphate bonds of ATP leads to the formation of H 2 0 and requires 3H in addition to the formation of the 1 H 0 formed from NADH plus H + plus 2e- taken from the substrates being oxidized by the cell. The reaction of oxidative phosphorylation is a spontaneous one (see Veech et al. in cited reference). The phosphorylation potential of living cells can be measured by determining the cellular contents of the components of certain metabolites (see Veech, R.L., in J. Biol. Chem. 254, 6538-6547, 1979). In certain tissues, such as brain, heart, or skeletal muscle, measurement of the components of the creatine kinase reaction (E.C. 2.7. 3.2) may be used as the preceding- reference describes. Since on theoretical grounds Veech et al. in J. Biol. Chem. 254, 6538-6547, 1979, showed that [creatine]/ [creatine-P] is in near-equilibrium with the cytoplasmic [sigma ATP]/[sigma ADP], it follows that the phosphorylation SUBSTITUTE SHEET -30- potential in skeletal muscle or brain may be evaluated in living cells by measuring the [sigma CrP]/[sigma Pi] ratio without resorting to freeze-clamping of the cells by the use of P NMR (nuclear-magnetic resonance) as has been done by Chance and others (see Chance, B. et al. Proc. Nat'l. Acad. Sci. , U.S. 78, 6714-6718, 1981). The agreement between the necessarily destructive methods heretofore used in animals by Veech, and the somewhat less precise but non-harmful methods of sigma creatine-P sigma Pi measurements with P NMR, demonstrate that the normal value of the phosphorylation potential or [sigma ATP]/[sigma ADP] [sigma Pi] as estimated by Veech is essentially correct (as stated above) . Further, the increasing availability of P NMR facilities in academic medical centers ensures that measurements in living cells, organs or whole organisms being treated in vitro can be conducted without harming them. Because the cytoplasmic [sigma ATP]/[sigma ADP] [sigma Pi] or phosphorylation potential is related to the cytoplasmic [NAD ]/[NADH] or redox state by a near- equilibrium reaction catalyzed by glyceraldehyde-3- phosphate dehydrogenase and 3-phosphoglycerate kinase, it is possible to alter and regulate and normalize the phosphorylation potential of a living cell by affecting its redox state (as is believed to be accomplished in the present invention) . If a simple, reliable chemical means were known and/or could be devised to change the intracellular redox state, it would of necessity have to change the other components of the reaction which include the phosphorylation potential and would be of obvious fundamental importance in medicine and in many other related fields of bio¬ chemistry, physiology, molecular biology, tissue culture, veterinary medicine, and like endeavors. Such a chemical means is provided by the teachings of the present invention. SUBSTITUTE SHEET -31- C_. Redox Active Metabolites As above indicated, a large portion of metabolism is devoted to energy generation which involves the removal of H + and e— from substrates in cytoplasm or mitochondria for delivery to mitochondrial electron transport scheme for conversion of 2H + plus 2e " with 1/2 0 2 to yield H 2 0 with the liberation of about 1 volt or 54 Kcal/mole of energy which is conserved in the [sigma ATP]/[sigma ADP] [sigma Pi] couple. In mammalian and other cells, the [sigma ATP]/[sigma ADP] [sigma Pi] has a delta G (free energy in calories per mole) of between -13.6 and -14.1 Kcal/mole. The transfer of this H and e " is accomplished by a series of co-factors, the major one being NAD (nicotinamide adenine dinucleotide) and its phosphate (called NADP) . Oxidation is defined as the removal of electrons, and reduciton as the addition of electrons. The removal or addition of e " plus H from substrates is catalyzed by enzymes, the major group of which are called dehydrogenases, as indicated above. The enzymes (catalysts) control the rates at which reactions occur, but the extent and the direction of a reaction, and the amount of energy (delta G) which may be liberated by a reaction, is deter¬ mined by the inherent energy in the chemical bonds (delta G°) and the concentrations of the reactants and products. Determination of any redox or energy state must always involve a ratio of chemical compounds, [product]/ [reactant] and [oxidized co-factor]/[reduced co-factor]. The overall reaction is thus comprised of two individual redox systems, one of which is oxidized, while the other is reduced. Those enzymes within a cell which are of sufficiently high activity relative to the flux through the enzyme to catalyze a state of near-equilibrium are suitable for controlling the redox state. A reaction may be experi- mentally determined to be in a state of near-equilibrium by measuring the equilibrium constant (K ) under con- ditions which approximate those exisiting within a cell, SUBS ITUTE SHEET -32- that is, where the ionic strength I equals 0.25, the pH equals 7 to 7.2, the temperature equals 38°C, and the free [Mg 2+] equals 0.5 to ImM, and also where I equals 1/2 sigma molarity of ions times the valence of ions. With knowledge of the value of K , the concentration of the reactants in a tissue may be measured in rapidly frozen tissue. If the value of [product]/[reactant] measured, in several couples gives the same co-factor ratio; then the reaction is said to be in "near-equilibrium", In the case of near-equilibrium dehydrogenase reactions, addition of a predetermined amount of a ratio of [product]/ [reactant] allows one to set the [NAD ]/[NADH] ratio within the cell at a predetermined level provided the reactants penetrate the cell wall freely or in a constant ratio one to another. The redox state of [NAD(P) ]/ [NAD(P)H] ratio may be set inside a cell by setting one or both of the [NAD ]/[NADH] ratios and controlling the [C0 2 ] with the range of 1.2 - 1.9 mM as stated in the preceding equation. Inclusion of [HCO, ]/[C0 2 ] in the bathing fluid at predetermined amounts controls pH in the media and within the cells. Various cytoplasmic and mitochondrial NAD-linked dehydrogenases appear to be capable of controlling or setting the [NAD ]/[NADH] ratio in each of cytoplasm and mitochondrium. However, only the enzymes LDH (L-latate dehydrogenase or E.C. 1.1.1.27), or D-B-hyroxybutyrate dehydrogenase possesses permeant metabolites capable of directly and completely regulating intracellular redox states in most cells. For example, one member or the other of such a redox couple may not be capable of permeating or penetrating a cell wall without a severe gradient in concentration being present. In other instances, one or the other of the partners of a redox couple when given above as is currently practiced in the art would lead to demonstratable toxicity when administered to a cell. I NSTITUTE SHEET -33- The near-equilibrium redox active metabolite carboxylate couples employed in the practice of the present invention, specifically, l-lactate /pyruvate and d-betahydroxybutyrate~/acetoacetate~, constitute safe entry points and appear to be unusual in their ability to not only normalize the redox state in cytoplasm through the reaction of l-lactate and pyruvate with LDH, but also to regulate the redox state in the mitochondrial through reaction of and D-betahydroxybutyrate and acetoacetate with the enzyme d-beta-hydroxybutyrate dehydrogenase (E.C. 1.1.1.30) which is apparently present in most tissues at a high enough activity to maintain near- equilibrium conditions at most times. As indicated above (see Table I and related text) , previous attempts to normalize the sodium to chloride milliequivalent mole ratio of about 1.36 were usually done in vitro by adding either lactate, pyruvate or acetate alone, or a combination of lactate and acetate, or other inappropriately paired carboxylate anions, leading inevitably in all known instances to severe and measurable pathological consequences. Such an attempt to normalize the Na:Cl ratio in iι vitro solutions, such as perfusion or tissue culture, has previously been attempted by Krebs in his serum substitute where he used a com- bination of glutamate " , fumarate " , and pyruvate " . (Krebs HA. B.B.A. 4_, 249, 1950) Such a combination led to severe tissue swelling due to abnormal uptake into the ce-1 of Na glutamate and pyruvate led to pathological distortion of the redox and phosphorylation state. No other attempt to control the Na:Cl ratio iri vitro is known to us. In the solutions of the present invention, one employs at least one of three different near-equilibrium couple mixtures. In each couple mixture, the two member components are employed in a definite milliequivalent ratio relative to one another. Such a ratio is needed in order to control either the plasma pH, or the redox state (and consequently the phosphorylation potential) , or both. S UBSTITUTE SHEET -34- Among the possible mixture couples which could be used, these three couples were selected because, for each- couple: (1) The distribution of ions between extra- cellular fluid and intracellular fluid is predictable in all normal and pathological states. (2) It is capable of achieving and regulating a predetermined redox state and for the phosphorylation potential within most living cells. (3) At least one member thereof contains an anionic charge. (4) It can be given in aqueous solution form so that the total levels administered do not substantially exceed total levels found under normal physiologic conditions in mammalian blood (plasma) . (5) Both members thereof constitute safe entry points which enter the metabo ' lic sequence and pathways at a safe entry point and these safe entry points, are at dead end terminals in the metabolic pathways, thus avoiding any possibility of a pathologic build up of metabolites with the consequence that a disordering of cellular metabolism would consequently result. When solution levels of, respectively, l-lactate/ pyruvate, d-betahydroxybutyrate/acetoacetate, and bicarbonate/C0 2 in the bathing fluid are maintained within their normal limits, then the redox state, the phosphorylation state, and the pH of fluids and cells each tend to be normalized which is achieved as a result of the use of such solutions. SUBSTITUTE SHEET -35- Intracellular concentrations of each member of each couple is achieved through the extracellular fluid because each of the monovalent anions chosen, namely, l-lactate and pyruvate, D-betahydroxybutyrate, and acetoacetate, and also bicarbonate, distribute themselves between extracellular water and intracellular water in concentra¬ tion ratios or gradients which are the inverse of the hydrogen ion, thereby achieving a gradient or ratio of about 1.35 between extracellular and intracellular fluid. The nonionic dissolved C0 2 distributes itself substantially equally between extracellular fluid and intracellular fluid. Those learned in the art realize a redox state must be defined at a certain pH, or [H ] ion concentration. The near-equilibrium couple [HCO, ]/[C0 2 ] defines the cellular pH or [H ] concentration. This near-equilibrium couple is therefore an integral part of the redox state. Preferably the level of sigma [HC0 3 ~] plus [C0 2 ] present in any given solution of this invention may vary under normal physiological conditions from about 10 mM/1 to 55 mM/1, but in general, is (when present) in the range from about 25 to 35 mM/1. The milliequivalent ratio of [HC0 3 ]/[C0 2 ], of course, in effect, is defined so as to give a [H ] ion concentration, or pH, in the physiological range as defined above. The redox and phosphorylation states in various tissues in the rat have been given by Veech et al. J. Biol. Chem. 254, 6538-6547, 1979 and for the redox states in Veech, Eggleston and Krebs, Biochem, J. , 115, 609, 619, 1969. The same general principles are believed to hold for most mammalian and avian cells. NMR measured estimates of the phosphorylation potential in brain and muscle in living humans, agree well with these figures derived by freeze-clamping procedures. e-* UBSTITUTE SHEET -36- By the term "plasma" or "blood plasma" as used herein, conventional general reference is had to the liquid part of the blood as distinguished from the corpuscles. Plasma can be prepared by various techniques well known to those familiar with this art typically using centrifugal force to separate a supernatant (which is plasma) after non-coagulated blood is centrifuged. By the term "extracellular fluid" as used herein conventional general reference is had to all body fluids in extracellular spaces outside of the circulatory system (e.g. the blood) and outside of intracellular fluid in a mammal (typically constituting about 15% of the weight of a mammal) . By the term "intercellular fluid" as used herein conventional general reference is had the fluid within cells which constitutes about 57% of total mammalian body weight. It is well known that (see Black, Lancet i, 305- 312 and 353, 1953) infusions into a mammal of large amounts sodium and chloride in a solution milliequivalent ratio of 1 to 1 lead inherently to hyperchloremic acidosis. This knowledge lead to the development of such well known solutions as Krebs serum substitute (B.B.A. 1950) lactated Ringers, and also to the compositions used and in most dialysis solutions, wherein, in a majority of cases, the sodium to chloride milliequivalent ratio is normalized compared to plasma values by the addition of various organic anions (as described above) . These organic anions chosen in the prior art areas described above. In no known prior art case, however, were any solutions with a normalized Na:Cl milliequivalent ratio produced which did not use organic ions in such a way as to inherently lead to severe and measurable metabolic abnormalities and pathologic consequences. Mixtures of redox pairs nor of HC0 3 /C0 2 were not used to normalize the Na:Cl ratio nor were the reasons known why a choice of near-equilibrium matched couples was desirable. Correction of this ratio • tween sodium cation and chloride anion by the mixture -37- couples as taught by the present invention eliminates the pathologic consequences of all the prior art electrolyte solution compositions. In addition, the solution compo¬ sitions of this invention teiid to normalize fluid inroganic electrolyte composition including the divalent 2+ 2+ cations Ca and Mg and to correct the anion gap which in many instances could not be accomplished by prior art electrolyte solutions. Thus, in summary, the compositions of this invention tend to normalize (a) fluid pH, (b) composition of major fluid inorganic electrolytes, (including the milliequivalent ratio of Na:Cl and the anion gap) , (c) the redox state, and (d) the phosphorylation potential. These normalizations are obtained and achieved without the abnormal, pathological consequences inherent in all known art solutions. No other man-made solutions are presently known which will accomplish this combination of results. D. Other Possible Benefits (Theorized) . It is theorized, and there is no intent to be bound by theory herein, that the solutions of the present invention, in addition to the properties above described, further tend to normalize at least one of the following states: (1) Distribution of water between intracellular and extracellular compartments, (2) Distribution of major inorganic electrolytes between intracellular and extracellular fluid, (3) Transmembrane cellular potential, and (4) The degree of organization within the cell or its entropy. The ratio of the chemical activity of water on each side of a typical normal mammalian cell membrane is always unity. Movement of water across such a cell membrane is achieved by the movement of osmotically active substances. Changing the cellular phosphorylation potential, through the NaK ATPase, therefore, inherently effects a change in the steady state level of ions inside and ions outside of .OSSTIITUTS SHEET -38- a cell with the net result being a change in the cellular water content in response to a change in the level of osmotically active substances on either side of the cell membrane. The transmembrane cellular potential is herein viewed as a Donnan potential (see Donnan, F.G. Chem. Rev. 1 : 73-90, 1924) resulting from the total amount of the non-diffusible osmotically active substances on either side of the cell membrane, and so is not a function of the so-called electrogenic sodium potassium ATPase, as is commonly held. (See The Cell, (1983)Alberts, B., Bray, D., Lewis, J. , Raff, M., Roberts, K. , and Watson, J.S., pp 294 Garland, New York.) Rather the Na/KATPase (E.C. 3.6.1.3) is viewed as an electro-neutral "osmopump" exporting a net of 1 Na " and 1 Cl " from intracellular to extracellular space for each ATP hydrolyzed. The reaction of the NaK ATPase is treated as the near-equilibrium link between intra and extracellular electrolytes in the manner given in equation 7. Cellular water volume can be measured by known (e.g. conventional) techniques involving the distribution of inulin and tritiated water. Distribution of major inorganic electrolytes between intracellular and extracellular fluid cna be measured by known (e.g. conventional) techniques, such as flame phtometry, atomic absorption spectoscopy, van Slyke gas analysis, and the like. Transmembrane cellular potential can be measured by known (e.g. conventional) techniques; such as with electrodes or microprobes, and the like. Calculation of such cellular voltage can be achieved from a measurement of the distribution of chloride ions between intracellular and extracellular fluid following Nernst's law. A quantitative relationship is theorized to exist involving redox state, phosphorylation potential and the above referenced three states. This relationship may be expressed by the following equation. (7.) SUBSTITUTE SHEET -39- 1 ΔG = 0 = ΔG° ATpase + ΔG° [Na out ] / [Na in ] . . . + RTln [Σ ADP ] [ Σ Pi] / [ Σ ATP ] + RT in { [Na + ] 0 3 / [Na + ] ± 3 x [K + ] ± 2 / [ κ+ ] χ ^-^ [c l - ] _ } + TΔS wherein : The values of the various terms in the foregoing equation of are given for muscle or brain as follows: (7.1) 10 ΔG = 0 = -7.73 kcal/mol + 0 + (-6.3 kcal/mol) + 8.4 kcal/mol + 5.6 kcal/mol In the foregoing equation, the phosphorylation potential is shown to be in a state of near-equilibrium 15 with the substrates of the sodium potassium ATPase. Since the chloride ion is cell wall permeable, this ion distri¬ butes itself in conformity with the transmembrane cellular potential. Movement of three sodium ions out of the cell and two potassium ions into the cell across the cell 20 membrane necessarily results, from the law of electrical neutrality, in the movement of one chloride ion from in¬ side the cell to outside the cell across the cell membrane. This makes the sodium potassium ATPase, in effect, an osmopump resulting in the export of two milliosmoles per 25 ATP hydrolysed. This pump is electroneutral. The T deltra S term, which is approximately 5.6 kilocalories per mole of ATP hydrolysed, is an entropy term. It, therefore, refers to the state of randomness within the cell. The positive nature of this entropy term 30 indicates that a high degree of order is imposed on the intracellular environment. In terms of quantum and statistical mechanics, the number of ways of achieving a certain energy state is called its degeneracy (Ω) . The Boltzman equation defines S (or entropy) as S-K- __>lnΩ, -j ς where Boltzmann's constant (which relates the gas constant to Avogadro's number), or K_ -23 a, = 1.38 x 10 J/°K. -- .T ϊ ~\-f". STtTUTE SHEET -40- It follows from the foregoing equation 7, above, that the distribution of calcium inside the cell is a funciton of the cube of the respective sodium concentra- < • tions inside and outside of the cell because of the action of the high-activity sodium-calcium exchange enzyme. The following equation shows the relationship: [Na÷^ 3 [Ca 2+ ] Q [Cl " ] i where: [] . intracellular concentration in cytoplasmic H 2 0 and [] concentration in extracellular H 2 0. Unlike the simple NaK ATPase which moves 2 mOsmoles out of the cell thus moving H-0 with it, the result of moving Ca 2+ out of the cell by the Na-Ca exchanger is to move a net of 3 mOsmoles into the cell, thus increasing the cell's water content. The NaK ATPase must then operate again to move the excess sodium out in exchange for K to restore osmotic equilibrium between extra¬ cellular space H 2 0 and cell H 2 0. The net result of the foregoing equation (7) is that the water of both intracellular and extracellular fluid is a funciton of the sodium/potassium ATPase (E.C. 3.6.1.3) and also of the phosphorylation potential. It can be empirically seen that the voltage across a cell membrane is inversely related to the chloride distribution and the phosphorylation potential. Correlation between phosphorylation potential, intracellular chloride and transmembrane cellular potential for various mammalian tissues is illustrated by Table II below: Correlation between Phosphorylation Potential, Intracellular Chloride and Transmembrane Cellular Potential. [∑ ATP] [Cl " ] ΔE [Σ ADP] [Σ Pi] mEq/1 mV red cell 7,000 90 - 9 Liver 15,000 40 -40 brain or muscle 30,000 7-9 -70 SUBSTITUTE SHEET -41- From the table above, it is seen that low phosphorylation potential correlates with a high intra¬ cellular chloride, and a low transmembrane cellular potential correlates with the inherent setting of the potential as a function of the Donnan-active material within the cell with the phosphorylation potential merely overcoming the Donnan forces so as to export two millios- moles, as described in equation 7. It follows, therefore, that the induction of high extra cellular chloride, such as occurs, for example, in current perfusion fluids, must have profound pathological consequences for the metabolism of the cell, even though the purpose of such is to preserve the natural character¬ istics of the tissue in vitro is to normalize the water and electrolyte concentrations of the various tissue cellular compartments. This is so because the ratio: {[Na + ] 0 3 :[K + ] i 2 .[Cl " ]} / {[Na + ± 3 . [K + ] o 2 .[Cl " ] i and the TΔS term link the cellular phosphorylation and the cellular redox states to intracellular and extracellular water and the electrolyte concentrations of Na , K , Cl , and also Ca E. Electrolyte Solution Preparation The electrolyte solutions of the present invention can be prepared by any convenient or conventional procedure. As a matter of accuracy, the compositions of this invention can be described in terms of their ion contents which can be expressed either in terms of millimoles per liter of solution, or milliequivalents per liter of solution. It is standard practice in this art in describ- ing a given solution to separate anions from cations, and nonionics from ionic materials; this practice is followed herein in the main. As those skilled in the art will readily appreciate, a translation or conversion of milli¬ moles per liter of solution, or of milliequivalents per liter of solution, into grams of a given salt added per liter of water is routine and is given in any standard text book in the field, such as, for example. Data For D ESTITU E -42- Biochemical Research (1969) (Dawson, R.M.C., Elliott, W.H., Jones, K.M., EDS) Clarendon Press, Oxford at pages 507 and 508. This reference illustrates not only the salt starting materials, but also the order of addition of same in the preparation of certain illustrative prior art electrolyte solutions shown therein. Solutions of this invention are readily prepared by this type of procedure. The particular salt combination used for a given solution may change from time to time in a manufacturing operation as those skilled in the art well know. The significant factor is that the final concentrations of respective component ions in any given solution remain as specified or desired. In view of the developed state of this art, no detailed description of electrolyte solution preparation procedures is believed to be necessary or desirable herein. The solutions of this invention, and the compon¬ ent-materials incorporated thereinto, are, in general, formulated, so as to achieve the desired physiological Na:Cl milliequivalent ratio normality, and the desired capacity to'regulate, correct, and normalize the conditions and states above identified herein. Thus, by this practice of this invention, one can accomplish in a physiologically acceptable manner the removal of metabolic products from cellular water, the replacement of cellular fluids and electrolytes, and the administration of nutrients, and the like, and the growth of cells in culture. The solutions may be administered in any fashion desired so long as they contact living tissue, cells or aggregations of cells. Contacting can be accomplished by any convenient technique, such as, for example, by perfusion of whole organs, across a semi-permeable membrane in cell suspensions, in tissue slices, in cells cultured either on plates, in roller "■ bottles, in suspensions and the like, as those skilled in the art will readily appreciate. The solutions of this invention as prepared are, in general, well suited for the administration of therapeutic agents to ce-ls in any form in vitro SUBSTITUTE SHEET -43- When bicarbonate anions are not present, then the level of combined (or sigma) 1-lactate/pyruvate and/or d-betahydroxybutyrate/acetoacetate present in a solution of this invention is optionally greater than when bicar- bonate is present in order to achieve the desired milli¬ equivalent ratio of sodium to chloride, as indicated. The concentration of either sigma l-lactate/pyruvate and/or of d-betahydroxybutyrate/acetoacetate in a given solution of this invention can thus range up to 80 mM. It is present preferred, particularly when no bicarbonate is present, to employ a mixture of 1-lactate/pyruvate with a mixture of d-betahydroxybutyrate/acetoacetate. Those skilled in the art will realize that in any given solution of this invention one can incorporate an excess of one or more individual members of any one mixture couple of this invention so that (a) the ratio of one member to the other of any given couple and (b) the total quantity of both mixtures or members lies outside of the ranges hereinabove described. Such a single member excess is not recommended when practicing the present invention. However, if such a single member excess does occur, the amount of the excess can be calculated by determining the maximum ratio of one couple member to the other which can be present in accord with the above teachings, and then the quantity of one couple member remaining (or present) which is outside of this ratio range may be considered to constitute an excess. The effect of such an excess is evidently merely to cut down, but not to eliminate, the efficacy of what effect would otherwise be obtained by using only a solution which contains mole ratios and quantities of respective mixture couples within the spirit and scope teachings of this invention. In the making of solutions of this invention, it is preferred to employ the optically active l-lactate salts or 1-lactic acid (which will make the desired L-lactate anions in solution) , and also similarly to -44- employ d-betahydroxybutyric acid or d-betahydroxybutyrate salts (will make the desired d-betahydroxybutyrate anions in solution) . Choice of particular salt or acid (or mixture) used in any given case depends among various factors, such as upon the other starting inorganic salts which a formulator desires to use (based upon availability, cost, and like factors) , all as will be readily appreciated by those skilled in the art. Racemic (d,l) mixtures could be used, but their use is preferably avoided. If such are used, the ratios of one member to another in the respective near-equilibrium couples involved should be based upon the quantity of particular optically active form present (e.g. either [l-lactate ] or [d-betahydroxybutyrate ], as the case may be) . The carbon dioxide, when used, can be introduced either as a gas, preferably using conventional aeration apparatus to effect a solubilization of C0 2 in a solution, or it can be generated in-situ from a dissolved metal (such as sodium, (preferred) , potassium, calcium or magnesium) salt of bicarbonate in combination with a dissolved acid (lactic, pyruvic, betahydroxybutyric, or acetoacetic) in respective proporations of each such that the total quantity of dissolved carbon dioxide so generated is within the ranges described herein for use in a solution of this invention. As elsewhere indicated herein, if desired, a solution of this invention can also contain various known additives such as, for example, as Basal Eagle's Media for use in tissue culture. For a listing of the small and varied components usually added to the "Balanced Salt Solution" of tissue culture media described here (see Eage, H. Science 122 501, 1955; Eagle, H. et al. Science 123, 845, 1956; Eagle, H. J. Biol. Chem. 214, 839, 1955; and many other similar lists of additives currently sold commer- cially as tissue culture media) . ■ SUBSTITUTE SHEET -45- In general, a solution of this invention should contain as a minimum of total of sigma (lactate/pyruvate and/or sigma betahydroxybutyrate/acetoacetate) and/or sigma bicarbonate/carbon dioxide which is at least about 0.1 millimoles per liter as indicated. Below these levels, benefits in normalization of body metabolism as explained above are apparently achievable, but such benefits become increasingly difficult to demonstrate and prove by state of the art techniques of measurement. Consequently, it is preferred to avoid, if possible, homeopathic possibil¬ ities by using minimum concentrations as above indicated. When bicarbonate is present, the total quantity of sigma (lactate/pyruvate and/or betahydroxybutyrate/acetoace- tate) used can generally be reduced which is now believed to be desirable. Thus, when bicarbonate is present, the total sigma (1-lactate/pyruvate and/or d-betahydroxybutyrate/ acetoacetate) is preferably about 2 to 17 millimoles per liter. When a solution of this invention contains at least one metabolizable nonionic or zwitterionic osmotically active substance, added to provide nutritional requirements no account of the proper Na:Cl ratio need be considered as for instance after addition of glucose and glutamine. When for examples, compounds like Na glutamate or lysine Cl is added in a nutritive mixture, amounts over 1 meq/1 can be compensated for by adjusting the Na and Cl within the basic balanced salt mixture. F. Compositions &_ Processes In su-mary, the present invention relates to an in vitro process of the type where living animal cells are contacted with an extracellular fluid which contains physiologically effective amounts of inorganic electrolytes. The improvement comprises (a) eliminating hyperchloremic from such cells so contacted by maintaining in said extra- cellular fluid a sodium to chloride milliequivalent ratio in the range from about 1.24 to 1.60, and (b) simultaneously maintaining in said cells: HEET -46- (1) a normal redox state, (2) a normal phosphorylation potential, and (3) a normal intracellular fluid pH by including in said extracellular fluid each of the following dissolved components in the respective amounts indicated: (A) at least one of the following near-equilibrium couples in the respective quantities indicated: (1) from 0 to about 55 millimoles per liter of a first couple mixture consisting of bicarbonate anions and carbon dioxide wherein the milli¬ equivalent ratio of said bicarbonate anions to said carbon dioxide ranges from about 8/1 to 50/1. (2) from 0 to about 55 millimoles per liter of a second couple mixture consisting of l-lactate anions and pyruvate anions wherein the milli¬ equivalent ratio of said l-lactate anions to said pyruvate anions ranges from about 20:1 to 1:1, (3) from about 0 to about 55 millimoles per liter of a third couple mixture consisting of d- betahydroxybutyrate anions and acetoacetate anions wherein the milliequivalent ratio of said d- betahydroxybutyrate to said acetoacetate ranges from about 6:1 to 0.5:1. (A) from about 130 to 170 millimoles per liter of sodium cations, (B) sufficient millimoles per liter of chloride anions to produce a milliequivalent ratio of sodium cations to chloride anions in the range from about 1.24 to 1.6, (C) optionally from 0 to about 6000 millimoles per liter of at least one osmotically active substantially nonionic substance, (D) from 0 to about 18 millimoles per liter, of total inorganic phosphate, (E) optionally at least one of the following additional cations in a respective quantity as indicated: , -47- quantity cation (in millimoles/liter) potassium 1 - 6 calcium 0 - 3 magnesium 0 - 1.3 the relationship between said water and all solutes in said water being such that said solution is characterized by having: (1) an osmolarity ranging from 260 to 6400 milliosmoles; (2) a pH in the range from about 6.9 to 7.8, (3) the charges of all cations equal the charges of all anions; and (4) the minimum total concentration of all said near-equilibrium couple(s) present in said solution is at least about 0.1 millimoles per liter. In summary compositions of this invention can be described by the following Table IV: TABLE IV Quantity Range Component (millimoles per liter) Total cations (mEq/L) about 130 to 170 ( 1) sodium about 130 to 170 (2) potassium about 0 to 6 (3) . . ++ calcium about 0 to 3 (4) ++ magnesium about 0 to 1.3 Total anions (mEq/L) about 130 to 170 (5) chloride " about 81 to 137 (6) bicarbonate " about 0 to 55 (7) l-lactate " plus pyruvate " about 0 to 55 (8) d-betahydroxybutyrate " + acetoacetate " about 0 to 55 (9) Pi "1 ' 8 about 0 to 18 (10) sum (6+7+8) about 26 to 80 Total nonionics about 0 to 6000 (1) carbon dioxide about 0 to 8.7 (2) others about 0 to 6000 SUBSTITU -48- the relationship between said water and said components being such that: (12) the milliequivalent ratio of HC0 3 " /C0 2 ranges from about 8.7/1 to 50/1, (13) the milliequivalent ratio of l-lactate / pyruvate " ranges from about 20/1 to 1/1, . (14) the milliequivalent ratio of d-betahydroxy- butyrate~/acetoacetate ranges from about 6/1 to 0.5/1, (15) the milliequivalent ratio of Na:Cl ranges from about 1.24-1.6 and preferably 1.30 - 1.45, (16) the osmolarity millimoles per liter ranges from about 260-6400, and (17) the solution pH ranges from about 6.9 to 7.8. In practice, the compositional limits of electrolytes used in (a) balanced salt solutions for tissue culture, (b) perfusion media for perfusion of organs, or (c) incubation media for tissue slices, minces, homogenates, or isolated cells and the like, are much smaller that the corresponding limits used in in. vitro solutions for electrolytes and fluid therapy where disordered conditions either prexist or are purposely being made (see, for example the iri vitro solutions described in my copending case identified by attorney's docket nos. P83,2198 and P85,1402 and U.S.S.N. 623,510). Also in practice, perfusion media may contain bovine serum albumin as known in the art (see Table II above) . If a non binding polyanion is used, no compensation is needed (for example, when carboxymethyl starch is sub¬ stituted for albumin) . In tissue culture it is not customary to add polyvalent anions in concentrations which require use of increased cation levels (since fetal calf serum is added typically as a 10% solution). Thus, in the main, the solutions of this invention are intended to provide an improved electrolytes composition with a normal Na:Cl ratio, a physiologic pH, and a regulation of redox state and phosphorylation state if desired. To such a B3 τ & τuτε SHEET ' -49- solution one may add any combination of nutrients, macromolecules, or the like so long as the sodium and chloride on such additives are compensated for so as to maintain such concentrations at those herein described. Osmotically active substances (including zwitterions) may be used as desired. It is clear that, basically, as Table III shows, the existing balanced salt mixtures are either Krebs-Henseleit with altered Ca & Mg (see Ex. 10, 22, 23, 24, and 25 of Table III) or Krebs Ringers phosphate (see Ex. 26 and 11 of Table III) . It is further clear from Table V that example 27-30 differs radically from prior art balanced salt solutions. They also differ from all prior art perfusion media (see Table II, Ex. 15-19) which have an abnormal Na:Cl ratio with the exception of solution 20, Table II which normalized the Na:Cl with acetate with the now known toxic consequences since acetate does not constitute a safe entry point. The way that the albumin was used in the prior art did not correct the abnormal Na:Cl ratio in the prior art solutions. In the prior art, albumin was sued to get improvied flow through capillaries improved viscosity during perfusion and reduced sticking together of cells during incubation. These prior art benefits may be utilized in the present invention if albumin is added to a balanced salt solution of the present invention. New results are obtained, not known to or achieved in, the prior art because, for one thing, the present solutions offer the ability to maintain a normal Na:Cl ratio and a normal anion gap. EMBODIMENTS The present invention is further illustrated by reference to the following examples. Those skilled in the art will appreciate that other and further embodiments are obvious and within the spirit and scope of this invention from the teachings of these present examples taken with the accompanying specification. _ . i & _ j TiTUTE SHEET -50- Examples 27-30 The compositions here described in Table V are balanced salt solutions of the present invention prepared as taught by Dawson et al. , reference cited. For comparison purposes, Table VI is provided with Examples 31-34 to illustrate the compositional differences which exist for compositions which contain polyanions. • 1 If: TUTS SHEET Table V. Mew Noraoc loreeic Salt Mixtures for Use in the Abscence of Polyamons 27 28 29 30 30a Units MOΠMI fcdox- Redox- Veech' Veech's Veech's Plasaa Balanced Balanced Salt's Hiniaal Mimeal Moles N.E.J.N. Norβo- Norβo- Salts Salts 283, 1285 chloreaic chlomic Mith Decreased L fluid 1970 Uater Na 136 - 145 138 139 142 142 142 K 3.5-5.0 4.5 4.5 4.5 4.5 4.5 Ca 2.1 -2.6 1.5 1.1 1.1 1.1 1.1 free (Ca2 . 1.06 1 [1.06] [1.06] Ng 0.75 - 1.25 0.7 0.6 0.56 0.56 0.56 free IKgP- I 0.53 ] [0.531 [0.53] &£q Cations 142.7-153.2 146.7 146.9 149.73 149.82 149.82 Ii _ Cl 100 - 106 102 102 102 102 102 l i IC0 3 26 - 28 29 29 29 45.79 29 E Pi 1 - 1.45 1.2 1.2 1. 1 1.1 1.1 SO 0.32 - 0.94 0.1 0 0 0 0 L - lactate 0.6 - l.β 11.6 8.85 10.27 - 10.2 pyruvate 1.7 0.89 1.47 - 1.47 Lact/pyr 7 10 7 7 D-fl-OHbutyrate 3 3 3 acetoacetate 1 2 2 i-HB/ acac 3 1.5 1.5 acetate Other IitEq anions 128.7-139.4 146.7 146.5 149.72 149.72 149.72 Na/Cl 1.28-1.45 1.35 1.36 1.39 1.39 1.39 ui • ] Glucose 3.9 - 5.6 0 0 10 10 10 or others 4 - 6 M urea - ■ -J Cθ2 0.99-1.39 1.54 1.54 1.54 2.29 1.54 pH 7.35-7.45 7.4 7.4 7.4 7.4 S 7.4 _•_ r -osa- £85 - 295 292 293 307 307 4- to 6,300 Use: Tissue A Alltteerr?n * ative Alternative Alternative For cryopreservation culture, to 27 to 28 to 27 without of tissues with physiologic redox control glycerol kinase experiments, organ perfusi on. Table VI. Noraochloreβic Salt Mixtures for Use ttith Polyanions. 31 32 33 34 Units Noraal Krebs Krebs Krebs Veech*s Plasaa Albuainate Albuainate Albuainate ♦ Polyanionate ■Mies N.E.J.H. ♦ L/P L/P i fl-HB/AcAc 283, 1285 L fluid 1970 j;| InEq Cations 142.7-153.2 148.5 153.5 155.5 149.73 l 100 - 106103 103 103 102 HCD 3 26 -26 29 29 29 29 ε Pi 1 - 1.45 1.2 1.2 1.2 1.1 L - lactate 0.6 - 1.8 4.375 4.375 pyruvate 0.625 0.625 Lact/pyr 7 7 D-fl-OHbutyrate 1.2 acetoacetate 0.8 i-HB/ acac 1.5 acetate \ 1 Other (Polyanionate) 0.73 Alb 0.73 Alb 0.73 Alb Carboxy-*ethyl starch n (-14.6 a£ς> (-14.6 ι£q) (-14.6 aEq) (-16.73 BEQ) αEq anions 128.7-139.4 148. B 153.6 155.8 149.73 ui ro Na/Cl 1.28-1.45 1.34 1.39 1.40 1.39 61ucose 3.9 - 5.6 - or others 02 0.99-1.39 1.54 1.54 1.54 1.54 PH 7.35-7.45 7.4 7.4 7.4 7.4 I rtsa 285 - 295 280.7 290.7 294.7 307 Use: 5 g» i Nith control with control Alternative to Na Albuainate of cytoplasaic of cytoplasnic albuain ■ultiple uses redox state I aitochondrial redox state -53- 1 Example 35 Fibroblasts are grown in tissue culture balance salt solutions of two types to which is added Eagles Basal Media to both salt mixtures. 5 Table VII Eagle's Nut nts Additives to Balanced Salt Mixtures BME (modified) (IX) Liquid without Glutamine COMPONENT mg/L 10 Dextrose 1000.0 Phenol Red.Na 17.0 Sodium Succinate 6H 2 0 AMINO ACIDS L-arginine HCI 21.06 15 L-cystine 12.01 L-cystine, Na~ L-glutamine L-histidine HCI H 2 0 10.50 L-isoleucine 26.23 20 L-leucine 26.23 L-lysine HCI 36.53 L-methionine 7.46 L-phenylalanine 16.51 L-threonine 23.82 25 L-tr ophan 4.08 L-tyrosine 18.11 L-valine -54 References: 1. Eagle, H. , 1955, Science 122:501 2. Eagle, H. , 1955, J. Exp. Med., 102:37 3. Eagle, H. , 1955, J. Exp. Med., 102:595 4. Eagle, H. , 1955, J. Biol. Chem., 234:839 5. Eagle, H. et al., 1956, Science, 123:845 6. Eagle, H. , 1955, Proc. Soc. Exp. Biol. Med. , * 89:362 7. Morton, H.J., 1970 in Vitro, 6:89 8. Hanks, J.H., Wallace, R.E. , 1949, Proc. Soc. Exp. Biol. Med., 71:198 The composition of the Balanced Salt Mixtures used are taken from Table III and Table V. -55- Table VIII Composition of 2 Balanced Salt Mixtures for Tissue Culture Earle's Veec 's Balanced Salt Salts mmoles/L Example 22-' Na 142 142 K + 5.4 4.5 Ca 2+ 1.8 1.1 Mg 2+ 0.8 0.56 meq Cations 152.6 149.73 Cl " 126.2 102 HCO, " 23.8 29 Pi "1 ' 8 1.0 1.1 so 4 2" 0.8 0 L-lactate 0 10.27 pyruvate 0 1.47 Lact/pyr - 7 D-B-Hydroxybutyrate 3 acetoacetate 0 2 HB/acac - 1.5 meq anions 153.4 149.72 Na:Cl 1.12 1.39 co 2 1.23 1.54 pH 7.4 7.4 mOsm 311 307 Methods: Cells are grown in roller bottles in the conventional manner, one in 5% C0 2 the other in 6% C0 2 with media changed every two days. Results: Growth Rate It is noted that the firbroblasts reach confluence in 7 days using salts from example 29 , but take 10 days to reach confluence using salts from example 22. It is con¬ cluded that the new salt mixture facilitates growth of cultured cells. i! B3T!T TE SHEET -56- Phosphorylation Potential: On day six of the culturing procedure, 1 hour after the media was changed, the cells were killed by addition of perchloric acid and then metabolite contents were measured as described in Veech et al J Biol Chem 254: 6538-6547, 1979, to evaluate their redox and phosphory¬ lation states. Table IX Earle's Sa s Veech's Salts example 22 example 29 cytoplasmic [NAD + ] 1,000 1,000 [NADH] cytoplasmic It is noted that the phosphorylation potential is significantly elevated in the cells grown in Earle's salts and normal for fibroblasts grown in the salt solution of the present invention. Morphology: Another set of cells is exposed to glutaraldehyde and fixed for electron microscopy. It is noted that fibroblasts grown in earle's salts have disordered or abnormal intracellular structure whereas those grown in the salt solution of the present invention appear like normal fibroblasts. It is noted that the phosphorylation state of cells incubated in Krebs Henseleit is abnormally elevated whereas that of cells incubated in so-called Krebs Albuminate solution of the present invention with a normal Na:Cl ratio have a normal phosphorylation state. Example 36 Hepatocytes are made and incubated as described by Crow, K.E., Cornell, N.W. & Veech, R.L. Alchoholism, Clin. & Exp. Res. 1. 43-47, 1977. » 'J S -_ SHEET -57- One set is incubated in Krebs-Henseleit solution to which is added 5 mM of a sum of Na lactate and Na pyruvate in a 7:1 ratio (example 10, Table III) and another set of cells is incubated with lactate/pyruvate as des¬ cribed in Krebs Albuminate solution of the present invention (example 32 Table VI) . After 1 hour incubation the cells are centrifuged into perchloric acid under bromododecane and their meta¬ bolite contents measured. Results: Table X - Nucleotide Ratios Krebs Krebs Henseleit Albuminate cytoplasmic [NAD] 1,500 1,500 [NADH] We note that the phosphorylation potential in cells incubated in Krebs-Henseleit with a Na:Cl rates of 1:12 is greater than the phosphorylation potential in hepatocytes incubated in Krebs-Albuminate where the Na:Cl ratio is 1:34. This shows that the NaCl ratio in the external media surroundg cells can influence the central internal energy status of the cell. It further shows that the system behaves like a near-equilibrium one. The teachings contained in my co-pending applications identified by attorney docket numbers P83,2198; P85,1402; P83,1593; and P85,1405 (ϋ.S.S.N.'s 623,510 and 623,101) are incorporated hereinto by reference in their entirety. It will be appreciated that many variations and further embodiments of the present invention will be apparent to those skilled in the art from the foregoing teachings and no unnecessary limitations are to be drawn therefrom. SUBSTITUTE SHEET

Claims: -58- CLAIMS 1. In an iri vitro process of the type where living animal cells are contacted with an extracellular fluid which contains physiologically effective amounts of inorganic electrolytes, the improvement which comprises (a) eliminating hyperchloremia from such cells so contacted by maintaining in said extracellular fluid a sodium to chloride milliequivalent ratio in the range from about 1.24 to 1.60, and (b) simultaneously maintaining in said cells: 1. a predeterminable redox state, 2. a predeterminable phosphorylation potential, and, 3.- a normal intracellular fluid pH by including in said extracellular fluid each of the following components in the respective amounts indicated: (A) at least one of the following near-equilibrium couples in the respective quantities indicated: (1) from 0 to about 55 millimoles per liter of a first couple mixture consisting of bi¬ carbonate anions and carbon dioxide where in the milliequivalent ratio of said bicarbonate anions to said carbon dioxide ranges from about 8.7:1 to 50:1, (2) from 0 to about 55 millimoles per liter of a second couple mixture consisting of l-lactate anions and pyruvate anions wherein the milliequivalent ratio of said l-lactate anions to said pyruvate anions ranges from about 20:1 to 1:1, (3) from about 0 to about 55 millimoles per liter of a third couple mixture consisting of d-betahydroxybutyrate anions and acetoacetate anions wherein the mi-liequivalent ratio of said d-betahydroxybutyrate to said acetoacetate ranges from about 6:1 to 0.5:1, ITUTE SHEET -59- (B) from about 130 to 170 millimoles per liter of sodium cations , (C) sufficient millimoles per liter of chloride anions to produce a milliequivalent ratio of sodium cations to chloride anions in the range from about 1.24 to 1.6, (D) optionally from 0 to about 6000 millimoles per liter of at least one osmotically active substantially nonionic substance, (E) from about 0 to 18 millimoles per liter of total inorganic phosphate, (F) optionally at least one of the following additional cations in a respective quantity as indicated: quantity cation (in millimoles/liter) potassium 0 - 6 calcium' 0 - 3 magnesium 0 - 1.3 the relationship between said water and all solutes in said water being such that said solution is characterized by having: (1) an osmolarity ranging from 260 to 6400 milliosmoles; (2) a pH in the range from about 6.9 to 7.8 (3) the charges of all cations equal the charges of all anions; and (4) the minimum total concentration of all said near-equilibrium couple(s) present in said solution is at least about 0.1 millimole per liter. 2. The process of claim 1 wherein said extra¬ cellular fluid is comprised of water which ahs dissolved therein each the following components in the respective amounts indicated: SUBSTITUTE SHEET -60- Quantity Range Component (millimoles per liter) Broadest Total cations about 130 to 170 (1) sodium about 130 to 170 (2) potassium about 0 to 6 (3) calcium about 0 to 3 (4) magnesium about 0 to 1. ' 3 Total anions about 130 to 170 (5) chloride " about 81 to 137 (6) bicarbona * » " about 0 to 55 (7) l-lactate ' plus pyruvate " about 0 to 55 (8) d-betahydroxybutyrate plus acetoacetate about 0 to 55 (9) sum 6 + 7 + 8 about 26 to 80 Total nonionics about 0 to 6000 (1) carbon dioxide about 0 to 8.7 (2) osmotically active substances about 0 to 6000 the relationship between the fluid components being as described in Claim 1. 3. The process of claim 2 wherein said process comprises perfusing a living organ from a mammal and said extracellular fluid contains nutrients. 4. The process of claim 2 wherein said process comprises tissue culture and said extracellular fluid contains from about 1 to 50 millimoles per liter of total nutrients. 5. The process of claim 1 wherein said fluid contains at least about O.lmM/1 total of said near- equilibrium couples. 6. In an in vitro process of the type where living animal cells are contacted with an extracellular fluid which contains nutrients and inorganic electrolytes, the improve¬ ments which comprises eliminating hyperchloremia from such cells so contacted by (a) maintaining in said extracellular fluid a sodium to chloride mill .equivalent ratio in the SU BSTITUTE SHEET -61- range from about 1.24 to 1.6, and while simultaneously maintaining (1) a normal cellular redox state, (2) a normal cellular phosphorylation potential, and, (3) a normal intracellular fluid pH, (a) without exceeding total extracellular phosphate concentrations of 1 to 1.5 mM and, (b) without altering the essential nutrients and wherein said extracellular fluid comprises water which has dissolved therein each of the indicated components in claim 2 in the respective amounts indicated. 7. In a composition of the type employed for contacting living animal cells and which contains nutrients and inorganic electrolytes, and the improvement which comprises substantially eliminating hyperchloremia from such cells contacted therewith by (a) maintaining in said composition a sodium to chloride milliequivalent ratio in the range from about 1.24 to 1.6 while simultaneously maintaining (1) a normal cellular redox state, (2) a normal cellular phosphorylation potential, and, (3) a normal intracellular fluid pH, without: (1) exceeding normal total inorganic phosphate levels in the range from about 1 to 1.5 mM/L, and (2) altering conventional quantities of essential nutrients, said composition comprising water which has dissolved therein the components specified in claim 2. 8. An electrolyte solution containing up to 6000 mosmoles of an osmotically active substance, which at the same time maintains normal tissue co-factor ratios, and a no--mal Na:Cl ratio. SHEET -62 9. A process whereby the solution of claim 8 is used in the cryopreservation of living tissues comprising contacting such tissues with such solution. SHEET '• -_?v -TVTUTE

Inventors: VEECH RICHARD L, VEECH, RICHARD, L.
Applicants: VEECH RICHARD L, VEECH, RICHARD, L.
Application year: 1985
Main classification: C12N5
IPC codes: A61K33, C12N5